Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF-System platelet-rich plasma and fibrin clot for perianal fistulas in Crohn's disease (Phase II)
2011-004820-37Phase 2Active
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Feb 2012
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of platelet-rich plasma and fibrin clot (PRGF-System) in anal fistula and Crohn's disease, sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Incidence of IMP-related adverse events. Started Feb 2012; status: active.
02
Drugs
platelet-rich plasma and fibrin clot (PRGF-System)
03
Conditions
anal fistulaCrohn's disease
Beyond the preview
Go deeper on 2011-004820-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004820-37.